AVR

1.61%

$15.25 anteris technologies ltd

"Take a Closer Look", page-688

First 688 Last

Share
Profile

Follow
suckii

527 Posts.

51

08/05/17

23:51

Post #: 24556359
Share

Originally posted by suckii ↑

Suckii's run down on the HSV-2 webinar:

The opening by WP to present the HSV-2 results to tell the SH's a little bit of the process from phase 1 (to educate the SH's of the process of the immunotherapy and where it is heading). And started by saying that he and Professor Frazer had run through the data to make sure that there on the same page and both are enthusiastic about the results.
The first statement was the FDA approval for the 3D Curved Patch, the next was the RNA-DNA therapeutic development company, the money shot signing the next phase in HSV-2B. Reassuring investors that we have the technology to progress here. (HSV-2B & HPV)
Run down from the beginning of the HSV-2 program to the present day. He made sure that he pointed out that the very most important fact from phase 1 is that we had a 95% activation then stating that in his 25 years in global pharmaceuticals that it is exciting to get this far in phase 2B and beyond and went on to mention about the RNA and the CD4 and CD8 response data.
Immuno-oncology targets, E6 & E7 antigen giving SH's an understanding of what to be looking at so able to refer back. ADMEDUS had a collaboration with a different company but please forgive me if I have got these names wrong and I would like someone to please help me here. I am not sure if it is Grana or Rana and Shia which are the two companies that have amalgamated but it looks like it's Rana that has something very good in the HPV field.
No capital from SH's and we have a great portfolio in all fields. Close of meeting is extremely positive, great data, strong collaborations with more to come, working on how to structure and fund the next level of expansion.

PS: I know my perspective and view differ to a lot of people on HC but it can't possibly be so far apart that people don't understand that ADMEDUS is a global heavy weight.

Expand

W.P Please give announcement ASAP the SP is testing our
patients

AHZ Price at posting: 30.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

SER

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

The Rising Tide: How institutional adoption is shaping the future of crypto

Reporting wrap: Inghams, Accent, Mayne Pharma

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

IPH

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

The business of sport: Warren Tredrea's take on this week's news

NRX

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

RDN

Raiden gears up for exploration in final quarter of 2024

Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions

There are more pages in this discussion • 540 more messages in this thread...

First 688 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $15.25		Change -0.250(1.61%)		Mkt cap ! $322.3M

Open	High	Low	Value	Volume
$15.50	$15.50	$14.80	$140.4K	9.315K

Buyers (Bids)

No.	Vol.	Price($)
1	297	$15.00

Sellers (Offers)

Price($)	Vol.	No.
$15.25	1300	2

View Market Depth

No.	Vol.	Price($)
1	60	14.800
1	206	14.500
1	1388	14.400
1	60	14.350
1	38	14.260

Price($)	Vol.	No.
15.250	1300	2
15.400	238	1
15.500	370	1
15.660	1925	2
15.950	848	2

Last trade - 16.10pm 23/08/2024 (20 minute delay)

AVR (ASX) Chart

"Take a Closer Look", page-688

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

The Rising Tide: How institutional adoption is shaping the future of crypto

Reporting wrap: Inghams, Accent, Mayne Pharma

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

The business of sport: Warren Tredrea's take on this week's news

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

Raiden gears up for exploration in final quarter of 2024

Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

"Take a Closer Look", page-688

Top Stories

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

The Rising Tide: How institutional adoption is shaping the future of crypto

Reporting wrap: Inghams, Accent, Mayne Pharma

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

The business of sport: Warren Tredrea's take on this week's news

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

Raiden gears up for exploration in final quarter of 2024

Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News